GOLDMAN SACHS GROUP INC - KURA ONCOLOGY INC ownership

KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 134 filers reported holding KURA ONCOLOGY INC in Q3 2023. The put-call ratio across all filers is 8.88 and the average weighting 0.3%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of KURA ONCOLOGY INC
ValueSharesWeighting
Q3 2023$4,202,469
-57.3%
460,797
-50.5%
0.00%
-50.0%
Q2 2023$9,843,188
-25.9%
930,358
-14.4%
0.00%
-33.3%
Q1 2023$13,291,564
-6.7%
1,086,800
-5.3%
0.00%0.0%
Q4 2022$14,240,363
-27.4%
1,147,491
-20.1%
0.00%
-40.0%
Q3 2022$19,613,000
+10.9%
1,435,792
+48.8%
0.01%
+25.0%
Q2 2022$17,689,000
+128.6%
965,026
+100.5%
0.00%
+100.0%
Q1 2022$7,738,000
+80.5%
481,190
+57.1%
0.00%
+100.0%
Q4 2021$4,288,000
-18.7%
306,277
+8.7%
0.00%0.0%
Q3 2021$5,276,000
+48.5%
281,717
+65.4%
0.00%0.0%
Q2 2021$3,552,000
-88.0%
170,343
-83.7%
0.00%
-85.7%
Q1 2021$29,514,000
-31.8%
1,044,008
-21.2%
0.01%
-41.7%
Q4 2020$43,284,000
+133.8%
1,325,297
+119.3%
0.01%
+140.0%
Q3 2020$18,516,000
+79.8%
604,296
-4.3%
0.01%
+66.7%
Q2 2020$10,296,000
+972.5%
631,712
+555.0%
0.00%
Q1 2020$960,000
-89.3%
96,441
-85.3%
0.00%
-100.0%
Q4 2019$8,991,000
+173.5%
653,852
+201.8%
0.00%
+100.0%
Q3 2019$3,287,000
-23.3%
216,670
-0.5%
0.00%0.0%
Q2 2019$4,288,000
-59.7%
217,747
-66.0%
0.00%
-66.7%
Q1 2019$10,638,000
+3659.0%
641,231
+3082.4%
0.00%
Q4 2018$283,000
-55.6%
20,149
-44.7%
0.00%
Q3 2018$637,000
-5.3%
36,426
-1.6%
0.00%
Q2 2018$673,000
+27.7%
37,003
+31.7%
0.00%
Q1 2018$527,000
+17.9%
28,103
-3.8%
0.00%
Q4 2017$447,000
+52.6%
29,222
+48.8%
0.00%
Q3 2017$293,000
-45.0%
19,632
-67.6%
0.00%
Q1 2017$533,000
+732.8%
60,530
+154.3%
0.00%
Q2 2016$64,000
+23.1%
23,800
+86.2%
0.00%
Q1 2016$52,00012,7810.00%
Other shareholders
KURA ONCOLOGY INC shareholders Q3 2023
NameSharesValueWeighting ↓
Foresite Capital Management IV, LLC 1,807,982$59,049,0006.41%
ACUTA CAPITAL PARTNERS, LLC 637,500$20,821,0005.67%
Asymmetry Capital Management, L.P. 346,518$11,317,0005.16%
Affinity Asset Advisors, LLC 260,000$8,492,0004.50%
EcoR1 Capital, LLC 1,773,037$57,907,0003.11%
VR Adviser, LLC 575,000$18,780,0002.76%
COMMODORE CAPITAL LP 133,503$4,360,0002.37%
Ghost Tree Capital, LLC 325,000$10,615,0002.36%
Avoro Capital Advisors LLC 4,000,000$130,640,0002.25%
SILVERARC CAPITAL MANAGEMENT, LLC 90,000$2,939,0001.71%
View complete list of KURA ONCOLOGY INC shareholders